At Xeris BiopharmaTM, we’re committed to making a difference in people’s lives through proprietary technology that brings life-changing solutions to diverse patient populations. From developing and commercializing unique therapies in endocrinology, neurology and gastroenterology to maintaining a robust pipeline of research and development programs for the future, we strive to make things better for healthcare providers and their patients. Our innovative, ready-to-use therapies help remove many of the associated burdens of and barriers to treatment, ultimately improving patients’ quality of life, and their overall health—and healthcare—experience. Why should Gvoke HypoPen® (glucagon injection) be co-prescribed with every insulin prescription?
Xeris Pharmaceuticals